CID 20055110

Schembl235186

Structural Information

Molecular Formula
C98H113N7O43
SMILES
C[C@H]1[C@@H]([C@@H](C[C@H](O1)O[C@H]2[C@H]3CC[C@@H](C4=C(C(=CC(=C4)O)O[C@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C6=C(C=CC(=C6)[C@H](C(=O)N3)NC(=O)[C@H]7C8=C9CC1=C(C=CC(=C1)[C@H]([C@@H]1C(=O)N[C@@H](C3=CC(=C(C(=C3)OC3=C(C=CC(=C3)[C@H](C(=O)N1)N)O)C)O)C(=O)N7)O)OC9=C(C1=C8CC3=C(O1)C=CC2=C3)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CO[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)C)O)O)O)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O[C@@H]1[C@@H]([C@H]([C@H](CO1)O)O)O)O)C(=O)OC)N)O
InChI
InChI=1S/C98H113N7O43/c1-30-50(111)20-39-22-54(30)138-55-21-33(5-12-49(55)110)63(100)88(127)105-67-70(115)35-7-13-52-37(15-35)18-44-62-45-19-38-16-36(8-14-53(38)140-84(45)87(83(44)139-52)148-98-86(78(123)74(119)59(144-98)29-135-94-80(125)75(120)69(114)32(3)137-94)147-97-85(77(122)73(118)58(27-107)143-97)146-95-79(124)71(116)51(112)28-134-95)82(145-60-25-46(99)68(113)31(2)136-60)47-10-9-41(93(132)133-4)42-23-40(108)24-56(141-96-81(126)76(121)72(117)57(26-106)142-96)61(42)43-17-34(6-11-48(43)109)64(89(128)101-47)102-91(130)66(62)104-90(129)65(39)103-92(67)131/h5-8,11-17,20-24,31-32,41,46-47,51,57-60,63-82,85-86,94-98,106-126H,9-10,18-19,25-29,99-100H2,1-4H3,(H,101,128)(H,102,130)(H,103,131)(H,104,129)(H,105,127)/t31-,32+,41-,46+,47+,51-,57+,58-,59-,60+,63+,64+,65-,66+,67+,68-,69+,70+,71-,72+,73-,74-,75-,76-,77+,78+,79+,80-,81-,82+,85+,86-,94-,95+,96+,97-,98+/m0/s1
InChIKey
SGAHMTIMAXYJKX-WDPGOHCNSA-N
Compound name
methyl (1R,2R,20R,21R,24R,36S,39R,42R,54S)-24-amino-2-[(2S,4R,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-11-[(2R,3S,4R,5R,6S)-3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-20,28,33,46,51-pentahydroxy-32-methyl-23,37,40,58,62-pentaoxo-49-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-30,66,67-trioxa-22,38,41,57,61-pentazatridecacyclo[40.14.2.221,36.13,7.16,10.19,39.112,16.115,19.125,29.131,35.143,47.048,53.013,60]octahexaconta-3(68),4,6,9,11,13(60),15,17,19(65),25(64),26,28,31(63),32,34,43(59),44,46,48(53),49,51-henicosaene-54-carboxylate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

249
Patents

2075.687 Da
Monoisotopic Mass

-5.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2076.6943 319.0
[M+Na]+ 2098.6762 336.1
[M-H]- 2074.6797 323.3
[M+NH4]+ 2093.7208 324.8
[M+K]+ 2114.6502 318.3
[M+H-H2O]+ 2058.6843 318.1
[M+HCOO]- 2120.6852 324.3
[M+CH3COO]- 2134.7009 324.5
[M+Na-2H]- 2096.6617 336.7
[M]+ 2075.6865 331.1
[M]- 2075.6875 331.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe